The Findings and Impact of Nonrehydrated Guaiac Examination of the Rectum (FINGER) Study
A Comparison of 2 Methods of Screening for Colorectal Cancer in Asymptomatic Average-Risk Patients
Edmund J. Bini, MD;
Roshini C. Rajapaksa, MD;
Elizabeth H. Weinshel, MD
Arch Intern Med. 1999;159:2022-2026.
Background Testing stool for occult blood at the time of digital rectal examination (DRE) has been discouraged because it is thought to increase the number of false-positive test results.
Objective To compare the diagnostic yield of colonoscopy and the cost per cancer detected in asymptomatic patients with a positive fecal occult blood test result obtained by DRE with that obtained from spontaneously passed stool (SPS) samples.
Methods We reviewed the medical records of consecutive asymptomatic patients at average risk for colorectal cancer who were referred for colonoscopy to evaluate a positive fecal occult blood test result obtained by DRE (n=282) or SPS samples (n=390). The cost of colonoscopy was estimated by adding the physician fee under Medicaid reimbursement, the facility fee for endoscopy, and the pathology fee for the biopsy specimens.
Results During the 5-year study period, 672 patients were evaluated and a colonic source of occult bleeding was identified in 145 patients (21.6%). The predictive value of a positive fecal occult blood test result (22.0% vs 21.3%, P=.85) and the cost per cancer detected ($7604.80 vs $7814.54) were no different in the DRE and SPS groups, with carcinomas being detected in 11.7% and 11.3% of patients, respectively.
Conclusions Testing stool for occult blood at the time of DRE does not increase the number of false-positive test results or the cost per cancer detected in asymptomatic patients at average risk for colorectal cancer. In this patient population, all individuals should be evaluated by full colonoscopy regardless of the method of stool collection.
From the Division of Gastroenterology, New York University Medical Center, Bellevue Hospital, and New York Veterans Affairs Medical Center, New York, NY.
RELATED ARTICLE
Archives of Internal Medicine Reader's Choice: Continuing Medical Education
Arch Intern Med. 1999;159(17):2094-2095.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Faecal occult blood tests - eliminate, enhance or update?
Fraser
Ann Clin Biochem 2008;45:117-121.
ABSTRACT
| FULL TEXT
Pelvic examination.
Seehusen et al.
NEJM 2007;357:1778-1779.
FULL TEXT
Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice
Collins et al.
ANN INTERN MED 2005;142:81-85.
ABSTRACT
| FULL TEXT
Colorectal Cancer Screening: Clinical Applications
Walsh and Terdiman
JAMA 2003;289:1297-1302.
ABSTRACT
| FULL TEXT
Screening for Colorectal Cancer in Adults at Average Risk: A Summary of the Evidence for the U.S. Preventive Services Task Force
Pignone et al.
ANN INTERN MED 2002;137:132-141.
ABSTRACT
| FULL TEXT
Fecal occult blood test for colorectal cancer screening
Strul and Arber
Ann Oncol 2002;13:51-56.
FULL TEXT
The Digital Rectal Examination and Occult Blood in the Stool: To Test or Not to Test?
JWatch Gastroenterology 2000;2000:9-9.
FULL TEXT
Does Stool Collection Method Affect Accuracy of Colon Cancer Screening?
JWatch General 1999;1999:2-2.
FULL TEXT
|
